Skip to main content

Scholar Rock Holding Corp 10-Q for FY2026 Q3

Scholar Rock Holding Corp (SRRK)

10-Q 2026-11-10 For: 2026-09-30
View Original
Added on November 10, 2026

About this 10-Q

Scholar Rock Holding Corp filed this 10-Q on November 10, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Scholar Rock Holding Corp launched ISEMBYLD after September 11, 2026 FDA approval, generating $0.6 million revenue for nine months ended September 30, 2026. It agreed to sell a priority review voucher to BioNTech US Inc. for $205.0 million. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$570K
compared with $0 a year earlier
Net loss
$107.24M
compared with a net loss of $102.22M a year earlier
Diluted EPS
-$0.81
compared with -$0.90 a year earlier